Arginine tango
As a means to evade the host immune response, S. aureus uses an enzyme called oleate hydratase, or OhyA, to inactivate antimicrobial unsaturated fatty acids in the membrane that would otherwise inhibit bacterial growth. Research scientists at St. Jude Children’s Research Hospital reported today the structure and catalytic mechanism of OhyA.
Christopher Radka of St. Jude’s Department of Infectious Diseases describes the research during a presentation Tuesday at 2 p.m. EDT at the 2021 ASBMB Annual Meeting, held in conjunction with the Experimental Biology conference.
Radka and colleagues used X-ray crystallography to determine the structure of OhyA. Solving and evaluating multiple OhyA crystal structures highlighted a coordinated dance that occurs between key arginine residues and the unsaturated fatty acid substrate in the active site of the enzyme, a process facilitated by the nucleotide cofactor FAD.

In this dance, the substrate is first guided into the binding tunnel by the oleate carbonyl of OhyA, then encounters its first arginine dance partner (Arg81) at the entrance of the active site. FAD binding then triggers the rotation of Arg81 that guides the fatty acid as it curls into the active site. After catalysis, a second arginine (Arg78) rotates behind the fatty acid carboxyl to release the hydroxylated product from the active site.
“What’s novel about the (active site) is how these conserved arginines guide the substrate through the donut-shaped active site,” Radka said. “Here, the arginines dance like two partners in a tango.”
This highly choreographed dance controls how the fatty acid substrate moves into and out of the active site. “In this coordinated tango at the active site, the FAD is the dramatic third character whose role is to come in and advance the dance so the chemistry can occur,” Radka said.
In this reaction, FAD remains oxidized and unconsumed. This quality is advantageous for industrial biotechnology research looking to use OhyA; FAD-dependent reactions often consume FADH2 and require continued starting product, which can be costly.
Future goals for this research include determining the structural elements required for S. aureus OhyA to remove antimicrobial fatty acids from the membrane.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Biochemists and molecular biologists sweep major 2025 honors
Recent Nobel, MacArthur and Kimberly Prize honorees highlight the power of biochemistry and molecular biology to drive discovery, including immune tolerance, vaccine design and metabolic disease, and to advance medicine and improve human health.

Spider-like proteins spin defenses to control immunity
Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.